Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

2.07
Delayed Data
As of 4:00pm ET
 -0.03 / -1.43%
Today’s Change
0.78
Today|||52-Week Range
4.25
-42.50%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close2.10
Today’s open2.09
Day’s range2.05 - 2.20
Volume721,185
Average volume (3 months)2,091,032
Market cap$34.0M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+86.71%
Earnings growth (this year)+57.38%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+67.16%
P/E ratioNM
Price/Sales42.25
Price/Book4.37

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...+0.05+2.78%
PBMDPrima BioMed Ltd-0.03-1.79%
FSIFlexible Solutions I...+0.01+0.55%
HTGMHTG Molecular Diagno...+0.08+3.72%
Data as of 4:00pm ET, 11/21/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$911.0K
Annual profit (last year)-$25.0M
Net profit margin-2,739.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Michael Ward
Chief Financial Officer
Jeffrey A. Whitnell
Corporate headquarters
Montréal, Qubec

Forecasts